ARTA
ACHV icon

A.R.T. Advisors’s Achieve Life Sciences ACHV Stock Holding History

A.R.T. Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-934
Closed -$32K – 1294
2019
Q3 		$32K Buy
+934
New +$36.7K ﹤0.01% 1346
2018
Q4 		– Sell
-730
Closed -$46K – 1270
2018
Q3 		$46K Buy
+730
New +$46.2K ﹤0.01% 1321
2016
Q3 		– Sell
-26
Closed -$57K – 623
2016
Q2 		$57K Sell
26
-5
-16% -$10.4K ﹤0.01% 1258
2016
Q1 		$46K Sell
31
-19
-38% -$31K ﹤0.01% 1293
2015
Q4 		$132K Buy
+50
New +$211K 0.01% 1293
2014
Q4 		– Sell
-23
Closed -$135K – 1385
2014
Q3 		$135K Sell
23
-23
-50% -$160K 0.01% 1175
2014
Q2 		$380K Buy
46
+39
+557% +$479K 0.02% 888
2014
Q1 		$175K Buy
+7
New +$172K 0.01% 1166

Other funds holding ACHV

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Searle & Co Greenwich, Connecticut $445M AUM 41.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

A.R.T. Advisors's ACHV Position: Q4 2019 in Review

A.R.T. Advisors sold out of Achieve Life Sciences (ACHV) in Q4 2019, closing a stake of 934 shares — an estimated $32K sold.

A.R.T. Advisors first reported a position in ACHV in Q1 2014 and held it in 8 quarters. The position peaked at $380K in Q2 2014. 17 funds tracked by Wall St. Rank hold ACHV as of Q4 2019.

  • A.R.T. Advisors reported no remaining Achieve Life Sciences position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 934 Achieve Life Sciences shares in Q4 2019, an estimated $32K.
  • A.R.T. Advisors first reported a position in Achieve Life Sciences in Q1 2014 and held it in 8 quarters.
  • A.R.T. Advisors's Achieve Life Sciences position peaked at $380K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.